Ameli Tropé

730 total citations
30 papers, 518 citations indexed

About

Ameli Tropé is a scholar working on Epidemiology, Oncology and Surgery. According to data from OpenAlex, Ameli Tropé has authored 30 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 13 papers in Oncology and 8 papers in Surgery. Recurrent topics in Ameli Tropé's work include Cervical Cancer and HPV Research (28 papers), Global Cancer Incidence and Screening (12 papers) and Genital Health and Disease (8 papers). Ameli Tropé is often cited by papers focused on Cervical Cancer and HPV Research (28 papers), Global Cancer Incidence and Screening (12 papers) and Genital Health and Disease (8 papers). Ameli Tropé collaborates with scholars based in Norway, Finland and United States. Ameli Tropé's co-authors include Mari Nygård, Tone Bjørge, Gry Baadstrand Skare, Christine Monceyron Jonassen, Stefan Lönnberg, A. Kathrine Lie, Suzanne Hetzel Campbell, Maarit K. Leinonen, Giske Ursin and Birgit Engesæter and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Journal of Clinical Microbiology.

In The Last Decade

Ameli Tropé

28 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ameli Tropé Norway 14 443 166 147 85 61 30 518
Esther Roura Spain 9 461 1.0× 250 1.5× 168 1.1× 50 0.6× 38 0.6× 19 575
Sara Smith United States 8 533 1.2× 319 1.9× 95 0.6× 101 1.2× 77 1.3× 14 656
Lesley Ashdown-Barr United Kingdom 12 741 1.7× 294 1.8× 190 1.3× 169 2.0× 208 3.4× 13 816
Kai-Li Liaw United States 15 567 1.3× 79 0.5× 318 2.2× 128 1.5× 54 0.9× 20 704
Heather Pedersen Canada 12 379 0.9× 254 1.5× 54 0.4× 56 0.7× 38 0.6× 26 530
Stella Heley Australia 9 386 0.9× 188 1.1× 127 0.9× 83 1.0× 48 0.8× 13 409
Gry Baadstrand Skare Norway 16 718 1.6× 327 2.0× 219 1.5× 103 1.2× 78 1.3× 28 824
Jennifer Young Pierce United States 18 299 0.7× 106 0.6× 80 0.5× 72 0.8× 73 1.2× 55 651
Olayinka Olaniyan Nigeria 11 376 0.8× 163 1.0× 114 0.8× 61 0.7× 31 0.5× 18 450
Philippa Holowaty Canada 10 466 1.1× 151 0.9× 175 1.2× 36 0.4× 58 1.0× 13 692

Countries citing papers authored by Ameli Tropé

Since Specialization
Citations

This map shows the geographic impact of Ameli Tropé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ameli Tropé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ameli Tropé more than expected).

Fields of papers citing papers by Ameli Tropé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ameli Tropé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ameli Tropé. The network helps show where Ameli Tropé may publish in the future.

Co-authorship network of co-authors of Ameli Tropé

This figure shows the co-authorship network connecting the top 25 collaborators of Ameli Tropé. A scholar is included among the top collaborators of Ameli Tropé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ameli Tropé. Ameli Tropé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bjørge, Tone, et al.. (2025). Cervical intraepithelial neoplasia grade 1 and long-term risk of progression and treatment. PLoS ONE. 20(4). e0320739–e0320739. 1 indexed citations
2.
Engesæter, Birgit, Irene Tveiterås Øvestad, Einar Gudlaugsson, et al.. (2025). The Predictive Impact of HPV Genotypes, Tumor Suppressors and Local Immune Response in the Regression of Cervical Intraepithelial Neoplasia 2-3: A Prospective Population-Based Cohort Study. International Journal of Molecular Sciences. 26(11). 5205–5205.
3.
Dillner, Joakim, et al.. (2024). Divergent effects of switching from cytology to HPV-based screening in the Nordic countries. European Journal of Public Health. 34(2). 354–360. 5 indexed citations
4.
5.
Portnoy, Allison, Kine Pedersen, Stephen Sy, et al.. (2023). Cost‐effectiveness of primary human papillomavirus triage approaches among vaccinated women in Norway: A model‐based analysis. International Journal of Cancer. 154(6). 1073–1081. 2 indexed citations
6.
Tollånes, Mette Christophersen, et al.. (2023). Livmorhalsprøvetaking i primærhelsetjenesten. Tidsskrift for Den norske legeforening. 143(11).
7.
Campbell, Suzanne Hetzel, Nathalie C. Støer, Philip E. Castle, et al.. (2022). Impact of the Mobile Game FightHPV on Cervical Cancer Screening Attendance: Retrospective Cohort Study. JMIR Serious Games. 10(4). e36197–e36197. 3 indexed citations
8.
Nygård, Mari, Birgit Engesæter, Philip E. Castle, et al.. (2022). Randomized Implementation of a Primary Human Papillomavirus Testing–based Cervical Cancer Screening Protocol for Women 34 to 69 Years in Norway. Cancer Epidemiology Biomarkers & Prevention. 31(9). 1812–1822. 15 indexed citations
9.
Tropé, Ameli, Mari Nygård, Irene Kraus Christiansen, et al.. (2022). HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial. British Journal of Cancer. 127(10). 1816–1826. 24 indexed citations
10.
Pedersen, Kine, Allison Portnoy, Stephen Sy, et al.. (2021). Switching clinic‐based cervical cancer screening programs to human papillomavirus self‐sampling: A cost‐effectiveness analysis of vaccinated and unvaccinated Norwegian women. International Journal of Cancer. 150(3). 491–501. 12 indexed citations
11.
Hashim, Dana, Birgit Engesæter, Gry Baadstrand Skare, et al.. (2020). Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening. British Journal of Cancer. 122(11). 1715–1723. 48 indexed citations
12.
13.
Solbrække, Kari Nyheim, et al.. (2019). Perspectives of non-attenders for cervical cancer screening in Norway: a qualitative focus group study. BMJ Open. 9(8). e029505–e029505. 14 indexed citations
14.
Lie, A. Kathrine, Ameli Tropé, Gry Baadstrand Skare, et al.. (2017). HPV genotype profile in a Norwegian cohort with ASC-US and LSIL cytology with three year cumulative risk of high grade cervical neoplasia. Gynecologic Oncology. 148(1). 111–117. 7 indexed citations
15.
Leinonen, Maarit K., Kristina Schee, Christine Monceyron Jonassen, et al.. (2017). Safety and acceptability of human papillomavirus testing of self-collected specimens: A methodologic study of the impact of collection devices and HPV assays on sensitivity for cervical cancer and high-grade lesions. Journal of Clinical Virology. 99-100. 22–30. 34 indexed citations
16.
Tropé, Ameli, et al.. (2017). Trygg implementering av HPV-testing i Livmorhalsprogrammet. Tidsskrift for Den norske legeforening. 137(17). 6 indexed citations
17.
Lönnberg, Stefan, et al.. (2016). Impact of scheduled appointments on cervical screening participation in Norway: a randomised intervention. BMJ Open. 6(11). e013728–e013728. 13 indexed citations
18.
Tropé, Ameli, Christine Monceyron Jonassen, Katrine Sjøborg, et al.. (2011). Role of high-risk human papillomavirus (HPV) mRNA testing in the prediction of residual disease after conisation for high-grade cervical intraepithelial neoplasia. Gynecologic Oncology. 123(2). 257–262. 13 indexed citations
19.
Tropé, Ameli, A. Kathrine Lie, Christine Monceyron Jonassen, et al.. (2010). HPV genotype distribution according to severity of cervical neoplasia. Gynecologic Oncology. 118(1). 29–34. 47 indexed citations
20.
Tropé, Ameli, Katrine Sjøborg, Anne Eskild, et al.. (2009). Performance of Human Papillomavirus DNA and mRNA Testing Strategies for Women with and without Cervical Neoplasia. Journal of Clinical Microbiology. 47(8). 2458–2464. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Esther Roura Breakdown of academic impact, for papers by Sara Smith Breakdown of academic impact, for papers by Lesley Ashdown-Barr Breakdown of academic impact, for papers by Kai-Li Liaw Breakdown of academic impact, for papers by Heather Pedersen Breakdown of academic impact, for papers by Stella Heley Breakdown of academic impact, for papers by Gry Baadstrand Skare Breakdown of academic impact, for papers by Jennifer Young Pierce Breakdown of academic impact, for papers by Olayinka Olaniyan Breakdown of academic impact, for papers by Philippa Holowaty
Rankless by CCL
2026